Lumida
/DHC
⌘K
Diversified Healthcare Trust

Diversified Healthcare Trust

DHC
$7.50USD-0.53%-0.04 today

MARKET CAP

1.8B

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $8

52W RANGE

$4
$10

AI Summary

Stalk
TrimMedium

DHC remains in a medium-term downtrend with clear lower highs and lower lows beneath the 9/20/50 EMAs. Although extremely oversold against the 200-day SMA support, relief rallies into the EMA resistance band are likely. Therefore, bearish engagement should be deferred and executed on any bounce into the 9/20/50 EMA zone.

  • SHOP NOI trending toward upper guidance, indicating resilient segment growth
  • Q2 FFO beat supports distribution outlook and highlights operational strength
  • Negative earnings yield signals weak profitability relative to equity
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Diversified Healthcare Trust (DHC) is a prominent player in the healthcare real estate investment trust (REIT) sector, focusing on senior housing and healthcare properties. The company maintains a diverse portfolio that includes senior housing operating properties and medical office buildings, aiming to provide essential services within the healthcare space. DHC's strategic positioning within a growing aging population and its emphasis on the Senior Housing Operating Portfolio (SHOP) sector align with the broader theme of rising healthcare demands and demographic shifts.

Bull says

  • SHOP NOI trending toward upper guidance, indicating resilient segment growth
  • Q2 FFO beat supports distribution outlook and highlights operational strength
  • Consensus “Moderate Buy” with $9.83 target implies ~11.5% upside
  • High momentum and positive revision trends suggest sustained investor interest
  • Aging population tailwind underpins long-term demand for senior housing
  • Cost initiatives may improve margins despite current yield challenges

Bear says

  • Negative earnings yield signals weak profitability relative to equity
  • Elevated interest-rate sensitivity may raise borrowing costs and squeeze margins
  • Q2 revenue $365.4M missed est. $370.8M, highlighting demand variability
  • Slower SHOP occupancy ramp may dampen near-term NOI growth
  • Small market cap and dividend yield pressure may limit appeal
  • Competitive and telehealth risks could erode DHC’s moderate moat

Investment themes with DHC

Residential REITs -1.05%

Stable income from diversified rental housing portfolios

WELL · PSA · VTR

Earnings Call · Q1 2024 · Mgmt. Guidance

Updated 05-07-2025bullish

Transcript signals

Bull points

  • I think as we've talked about last quarter kind of the strategy there is we were in a good position to kind of acquire that 34% at the tender and kind of given the meaningful progress that Aleris had made as a private company with reducing costs and kind of further kind of expanding on their strategy to drive performance is just it was a good investment on the onset to come in at that value kind of lower relative to where we are today.
  • As we look across maybe the next 3 quarters, we're projecting about 250,000 square feet in our occupancy numbers, which I'll provide for kind of new leasing, along with the retention outside of the known vacates that I highlighted.
  • I think as we've talked about last quarter kind of the strategy there is we were in a good position to kind of acquire that 34% at the tender and kind of given the meaningful progress that Aleris had made as a private company with reducing costs and kind of further kind of expanding on their strategy to drive performance is just it was a good investment on the onset to come in at that value kind of lower relative to where we are today.
Read full transcript analysis ›